LivaNova PLC (LIVN) is a Healthcare · Medical Devices company listed on NASDAQ. Price $78.03 (+0.31%), Market cap $3.94B, P/E ratio 36.55, 52-week low–high $41.13 ~ $72.44.
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implan
Financial statements, price targets, institutional (13F) holdings and related news for LivaNova PLC are updated in real time on BlackAll Trade.
LivaNova PLC trades at $78.03 (+0.31%). Real-time quotes and charts are available on BlackAll Trade.
LivaNova PLC has a market cap of about $3.94B. Its P/E ratio is 36.55.
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the